A digital therapeutic (CT-152) as adjunct to antidepressant medication: A phase 3 randomized controlled trial (the Mirai study)

20257 citationsJournal Article

Authors

Good health and well-being

Published in: Journal of Affective Disorders

Volume 388, pp. 119409-119409

Field-Weighted Citation Impact: 10.53